Parkinson's Disease Patients Begin Receiving 'Neural Reboot' Treatment, Regaining Ability to Walk in Days
In a groundbreaking clinical trial that has stunned the medical community, patients with advanced Parkinson's disease are experiencing a dramatic reversal of symptoms thanks to a new "neural reboot" therapy. The treatment, which combines a targeted nanoparticle injection with a low-frequency electromagnetic pulse, rewires damaged neural pathways, allowing patients to regain motor control within 72 hours. Analysts predict that portable home-use devices will be available within five years, potentially ending the disease's grip on 10 million lives by 2035.